Second Drug Safety Monitoring Board (DSMB) meeting update planned for mid-January 2026 Topline results on track for the second quarter of 2026 SALT LAKE CITY, ...

The "Pharmaceutical Safety Assessment Global Market Report 2025" has been added to ResearchAndMarkets.com's offering.The pharmaceutical safety assessment market has demonstrated significant growth, ...

The "Pharmaceutical Safety Assessment Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The pharmaceutical safety assessment market has demonstrated significant growth ...

Biogen has received an NOC from Health Canada for Zurzuvae, a NAS, as a treatment for moderate or severe PPD in women.

The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.

Investors interested in arranging a meeting with company management during the conference should contact the Bank of America conference coordinator. A live audio webcast of the presentation can be ...

With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...

Virginia will be home to a workforce training and education center preparing thousands of people each year for a career in the pharmaceutical industry. The Virginia Center for Advanced Pharmaceutical ...

Pfizer's deal with the U.S. government, a robust pipeline, and a reasonable valuation make it a compelling buy. Eli Lilly's fantastic financial results and impressive innovative abilities paint a ...